GSKWEB3

pressroom

press releases
9/2/2009 - New Statement from GSK to address alli and Liver Disease Concerns
It’s important consumers know that alli is safe and effective and there’s no evidence to suggest alli causes liver damage.
view article
8/25/2009 - alli statement on FDA hepatotoxicity issues
GSK stands firmly behind the safety and efficacy of alli.
view article
2/7/2007 - Reality Council Welcomes the FDA Approval of alli
Experts on nutrition, obesity, diabetes and healthcare policy welcome alli as a supplement that may help some of the 130 million overweight and obese Americans achieve their weight loss goals.
view article
more news
events